Home > Insider Trading > Filing (0000899243-22-038819)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
31791	Perkinelmer Inc	PKI	Laboratory Analytical Instruments (3826)	042052042

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1519218	Andrew Okun	940 Winter Street Waltham MA 02451	Please See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-15	4,800	$92.09	11,191	No	4	M	Direct
Common Stock	Acquisiton	2022-12-15	3,350	$96.06	14,541	No	4	M	Direct
Common Stock	Disposition	2022-12-15	4,995	$140.82	9,546	No	4	S	Direct
Common Stock	Disposition	2022-12-15	3,155	$141.21	6,391	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	NQ Stock Option (right to buy)	Disposition	2022-12-15	4,800	$0.00	4,800	$92.09
Common Stock	NQ Stock Option (right to buy)	Disposition	2022-12-15	3,350	$0.00	3,350	$96.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-02-05	No	4	M	Direct
1,675		2027-01-30	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8	Indirect	By 401(K)

Footnotes

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Okun on November 15, 2022.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.04 to $141.01. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $141.04 to $141.77. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.
This option became exercisable in three equal annual installments beginning on January 30, 2021, which was the first anniversary of the date on which the option was granted.